Former Executive Vice President, Chief Regulatory Officer · Atara Biotherapeutics, Inc. (ATRA)

Jill Henrich

FY2024 is the first fiscal year CompBrief holds for Jill Henrich as a named executive officer of Atara Biotherapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$812,547

Salary $503,846Stock awards $252,000Bonus $44,979

5th of 5 named executive officers at Atara Biotherapeutics by FY2024 total.

5 named officers on file for Atara Biotherapeutics, FY2024

Jill Henrich’s pay file — $29

  • 1 fiscal year of pay, line by line
  • ATRA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Atara Biotherapeutics’s whole pay program stands against its peers

  • Atara Biotherapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Jill Henrich’s full pay file as a PDF — free

More than this page: up to 10 years of Jill’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jill Henrich compensation by year

Atara Biotherapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Atara Biotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$503,846
Bonus$44,979
Stock awards$252,000
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$11,722
Total$812,547

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Atara Biotherapeutics, Inc. DEF 14A filed April 28, 2025, accession 0000950170-25-059322, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Atara Biotherapeutics, Inc. filed document, accession 0000950170-25-059322. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU11,250$149,738—
RSU700$9,317—
RSU353$4,698—
RSU57$759—
Option665—$255.25
Option1,574—$97.75
Option87—$427.63

Per the Outstanding Equity Awards at Fiscal Year-End table in Atara Biotherapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Atara Biotherapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Pascal TouchonFormer President and Chief Executive Officer$1,722,332
AnhCo NguyenPresident and Chief Executive Officer$1,573,716
Eric HyllengrenFormer Executive Vice President, Chief Financial Officer and Chief Operating Officer$926,137
Amar MuruganFormer Executive Vice President, Chief Legal Officer$878,428
Jill Henrich · this pageFormer Executive Vice President, Chief Regulatory Officer$812,547

The full Atara Biotherapeutics compensation record

free company brief

This page is one person within Atara Biotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Atara Biotherapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Atara Biotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jill Henrich's compensation dossier · One-time report. No refunds.